CD4 and chronic obstructive pulmonary disease: Altogether, these results indicate that circulating CD4+CD25−Foxp3+ T cells at least partially represent an intermediate stage of natural life-cycle of T cells and might perpetuate chronic inflammation in COPD patients (Figure 8).